key: cord-1026260-8fdzfitl
authors: Miyashita, Naoyuki; Nakamori, Yasushi; Ogata, Makoto; Fukuda, Naoki; Yamura, Akihisa; Ishiura, Yoshihisa; Nomura, Shosaku
title: Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings
date: 2022-02-10
journal: J Infect Chemother
DOI: 10.1016/j.jiac.2022.02.005
sha: 4d168d18a06d47100e26bbd4b06b6e93521608d2
doc_id: 1026260
cord_uid: 8fdzfitl

INTRODUCTION: The Japanese Respiratory Society (JRS) scoring system is a useful tool for identifying Mycoplasma pneumoniae pneumonia. Most COVID-19 pneumonia in non-elderly patients (aged <60 years) are classified as atypical pneumonia using the JRS scoring system. We evaluated whether physicians could distinguish between COVID-19 pneumonia and M. pneumoniae pneumonia using chest computed tomography (CT) findings. In addition, we investigated chest CT findings if there is a difference between the variant and non-variant strain. METHODS: This study was conducted at five institutions and assessed a total of 823 patients with COVID-19 pneumonia (335 had lineage B.1.1.7.) and 100 patients with M. pneumoniae pneumonia. RESULTS: In COVID-19 pneumonia, at the first CT examination, peripheral, bilateral ground-glass opacity (GGO) with or without consolidation or crazy-paving pattern was observed frequently. GGO frequently had a round morphology (39.2%). No differences were observed in the radiological findings between the non-B.1.1.7 groups and B.1.1.7 groups. The frequency of pleural effusion, lymphadenopathy, bronchial wall thickening and nodules (tree-in-bud and centrilobular) was low. In contrast to COVID-19 pneumonia, bronchial wall thickening (84%) was observed most frequently, followed by nodules (81%) in M. pneumoniae pneumonia. These findings were significantly higher in M. pneumoniae pneumonia than COVID-19 pneumonia. CONCLUSIONS: Our results demonstrated that a combination of the JRS scoring system and chest CT findings is useful for the rapid presumptive diagnosis of COVID-19 pneumonia in patients aged <60 years. However, this clinical and radiographic diagnosis is not adapted to elderly people.

Coronavirus disease 2019 , caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), follows a biphasic pattern of illness that likely results from the combination of an early viral response phase and an inflammatory second phase [1] . Although most clinical presentations of COVID-19 are mild, approximately 20% of those infected with SARS-CoV-2 are known to develop moderate to severe lifethreatening pneumonia with respiratory failure [1] . Many outbreaks of COVID-19 have occurred in families, education facilities, child welfare facilities, welfare facilities for persons with disabilities, long-term care health facilities and medical institutions. To reduces the risk of outbreaks and prevent the infection spread, early identification of COVID-19 is important.

The term 'atypical pneumonia' was first applied to viral community-acquired pneumonia (CAP), which is clinically and radiologically distinct from bacterial CAPs. pneumonia using multiple regression analysis [2] . In a recent study, we evaluated whether the JRS scoring system could be used to differentiate COVID-19 pneumonia from bacterial pneumonia. The diagnostic sensitivity for COVID-19 pneumonia was 95.5% for non-elderly patients (aged <60 years) and 32.5% for elderly patients (age ≥60 years) [3] . After the start of vaccination against SARS-CoV-2, infection is centred on The intralobular lines in GGO described as crazy-paving appearance were not classified as characteristic of an area of reticular or linear opacity. A centrilobular nodule was defined as a nodule identified around the peripheral pulmonary arterial branch es, 3 to 5 mm away from the pleura, interlobular septa, or pulmonary veins. Bronchial wall thickening was defined as thickening that identified widespread areas not close to GGO and/or consolidation areas. Mediastinal lymphadenopathy was judged to be present when the minimal diameter of the lymph node was >10 mm. Hilar lymphadenopathy was judged to be present only if the maximum diameter of the ipsilateral hilum exceeded that of the contralateral hilum by 1.5-fold or more. The final decisions regarding the presence of each finding and opacity pattern for each case were reached by consensus among the three radiologists. In COVID-19 pneumonia, at the first CT examination, peripheral, bilateral GGO with or without consolidation or crazy-paving pattern was observed frequently ( Figure   1A ). GGO frequently (39.2%) had a round morphology ( Figure 1B) . Multifocal, diffuse, perihilar, or unilateral GGO with or without consolidation lacking a specific distribution and that was nonrounded or non-peripheral were also observed. No differences were observed in the radiological findings between the non-B.1.1.7 groups and B.1.1.7 groups (Table 1 ). The frequency of pleural effusion, lymphadenopathy, bronchial wall thickening and nodules (tree-in-bud and centrilobular) was low (Table 1 ). In contrast to COVID-19 pneumonia, bronchial wall thickening (84%) was observed most frequently, followed by nodules (tree-in-bud and centrilobular) (81%) in M. pneumoniae pneumonia, and these findings were significant ( Table 1 ).

The median age was significantly younger in M. pneumoniae pneumonia than COVID-19 pneumonia (p<0.001, Table 1 ). Thus, we further analyzed the patterns of abnormality with COVID-19 pneumonia on chest CT between the non-elderly patients J o u r n a l P r e -p r o o f 7 (aged <60 years) and elderly patients (age ≥60 years). The frequency of bronchial wall thickening and nodules (tree-in-bud and centrilobular) was low even in the non-elderly patients ( Table 2) . No significant differences were observed in the radiological findings between the non-elderly patients and elderly patients ( Table 2) .

We analyzed serial CT findings over time in 363 patients in COVID-19 pneumonia. Figure 2 shows the temporal changes in COVID-19 pneumonia. In the first week after symptom onset, the predominant pattern of abnormality was GGO (70.2%), followed by a mixed pattern (15.0%) and consolidation (14.8%) (Figure 2A ). In the second week after symptom onset, as the disease progressed, GGO was still the predominant CT finding (51.7%), followed by a consolidation (28.2%) and mixed pattern (20.1%) ( Figure 2B ). In the third week after symptom onset, GGO (42.3%) and mixed pattern (37.3%) were the predominant imaging patterns, followed by consolidation (9.1%), reticular pattern (8.1%), and normal pattern (3.2%) ( Figure 2C ).

It is well known that it is difficult to suspect the COVID-19 pneumonia in the clinical findings exception of presence of loss of taste and anosmia in the daily clinical setting [3] . Among the diagnostic methods, RT-PCR assay is thought to be the gold J o u r n a l P r e -p r o o f standard for diagnosing COVID-19. However, with oropharyngeal and nasopharyngeal swab specimens, the sensitivity of RT-PCR is not high and depends on the time of collection and the collector [5] . In addition, RT-PCR assay is not a point of care testing in daily clinical situations. Furthermore, some physicians do not carry out the RT-PCR or antigen detection test to avoid the droplet infection or airborne infection in the examination room. Thus, simple, rapid and not dangerous testing for diagnosing COVID-19 is important.

In a recent study, we demonstrated that the JRS scoring system is a useful tool for distinguishing between COVID-19 pneumonia and bacterial pneumonia in patients aged <60 years [3] . In addition to the JRS scoring system, physicians often performed chest CT as an auxiliary diagnostic test to differentiate between atypical pneumonia and bacterial pneumonia for the selection of antibiotics. The present results indicate that the diagnosis of M. pneumoniae pneumonia would appear reliable when a combination of bronchial wall thickening and tree-in-bud and centrilobular nodules and/or GGO with lobular distribution are found on CT findings. Our findings on chest CT among patients with COVID-19 pneumonia were consistent with those of previous reports with J o u r n a l P r e -p r o o f peripheral GGOs with or without consolidation or a crazy-paving pattern and multifocal GGO with rounded morphology [6] [7] [8] [9] [10] [11] [12] . Bronchial wall thickening and tree-in-bud and centrilobular nodules are rarely observed in COVID-19 pneumonia. Thus, physicians can differentiate COVID-19 pneumonia from M. pneumoniae pneumonia using chest CT findings.

Temporal changes in chest CT findings with COVID-19 pneumonia are consistent with previous reports [13, 14] . Although 71.6% of patients had normal chest auscultatory findings at the first examination (Figure 2A ) [3] , different adventitious sounds were heard as time progressed (coarse crackles in Figure 2B and fine crackles in Figure 2C ). Thus, physicians should be aware that chest auscultatory findings depend on the timing of the examination when the JRS scoring system is used.

Our study had several limitations. First, routine screening CT to identify COVID-19 pneumonia is currently not recommended by most radiology societies. However, the sensitivity of PCR assays is not high. Ai et al. investigated the diagnostic value and consistency of chest CT compared to the PCR assay in COVID-19 [15] . Of the 1,014 patients, 59% had positive PCR results and 88% had positive chest CT scan findings.

J o u r n a l P r e -p r o o f results. Thus, we suggest that chest CT may be considered a primary tool for COVID-19 detection in epidemic areas. Second, we excluded patients with severe COVID-19 pneumonia. The JRS scoring system applies only to mild-to-moderate pneumonia [3] .

Furthermore, some parameters of the JRS scoring system, especially chest auscultatory findings, were subjective. Thus, individual physicians may differ in their judgments about them.

As vaccination against SARS-CoV-2 progresses, infection in elderly people (age ≥60 years) has markedly reduced, and the number of infected people in their 20s to 40s has increased. In this situation, combination with the JRS scoring system and chest CT findings are useful tools for the rapid presumptive diagnosis of COVID-19 pneumonia.

However, this clinical and radiographic diagnosis is not adapted to elderly people.

J o u r n a l P r e -p r o o f 

Virology, transmission, and pathogenesis of SARS-CoV-2

Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections. Guidelines for the management of community acquired pneumonia in adults, revised edition

Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines

Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography

Detection of SARS-CoV-2 in different types of clinical specimens

Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study

Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis

Chest CT imaging signature of coronavirus disease 2019 infection: in pursuit of the scientific evidence

Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

The authors declare that they have no competing interests.